Search
for
Sort by
Research 30 of 69
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Drug-induced alopecia after dupilumab therapy
- Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report
- Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Dupilumab‐induced psoriasis in a patient with atopic dermatitis and alopecia totalis: A case report and literature review
- Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
- Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
- Dupliumab therapy for alopecia areata: a case series and review of the literature
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis
- Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis
- Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
- Dupilumab in a 9-week-old with Netherton Syndrome Leads to Deep Symptom Control
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- Friend or foe: A systematic review of dupilumab and alopecia areata
- Biologics in the management of childhood atopic dermatitis
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- 735 - A case series of dupilumab for vitiligo and alopecia areata in the setting of AD
- Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Drug-induced subacute cutaneous lupus erythematosus secondary to Dupilumab: A case report
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Time to loss of response for dupilumab in ophiasis-pattern alopecia areata
- Dissecting Cellulitis of the Scalp Associated With Dupilumab: A Paradoxical Neutrophilic Reaction
- Netherton syndrome: effect on ichthyosis linearis circumflexa with dupilumab
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis